Abstract:Abstract Alzheimer’s disease (AD) is the most common type of dementia. Its diagnosis and progression detection have been intensively studied. Nevertheless, research studies often have little effect on clinical practice mainly due to the following reasons: (1) Most studies depend mainly on a single modality, especially neuroimaging; (2) diagnosis and progression detection are usually studied separately as two independent problems; and (3) current studies concentrate mainly on optimizing the performance of complex machine learning models, while disregarding their explainability. As a result, physicians struggle to interpret these models, and feel it is hard to trust them. In this paper, we carefully develop an accurate and interpretable AD diagnosis and progression detection model. This model provides physicians with accurate decisions along with a set of explanations for every decision. Specifically, the model integrates 11 modalities of 1048 subjects from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) real-world dataset: 294 cognitively normal, 254 stable mild cognitive impairment (MCI), 232 progressive MCI, and 268 AD. It is actually a two-layer model with random forest (RF) as classifier algorithm. In the first layer, the model carries out a multi-class classification for the early diagnosis of AD patients. In the second layer, the model applies binary classification to detect possible MCI-to-AD progression within three years from a baseline diagnosis. The performance of the model is optimized with key markers selected from a large set of biological and clinical measures. Regarding explainability, we provide, for each layer, global and instance-based explanations of the RF classifier by using the SHapley Additive exPlanations (SHAP) feature attribution framework. In addition, we implement 22 explainers based on decision trees and fuzzy rule-based systems to provide complementary justifications for every RF decision in each layer. Furthermore, these explanations are represented in natural language form to help physicians understand the predictions. The designed model achieves a cross-validation accuracy of 93.95% and an F1-score of 93.94% in the first layer, while it achieves a cross-validation accuracy of 87.08% and an F1-Score of 87.09% in the second layer. The resulting system is not only accurate, but also trustworthy, accountable, and medically applicable, thanks to the provided explanations which are broadly consistent with each other and with the AD medical literature. The proposed system can help to enhance the clinical understanding of AD diagnosis and progression processes by providing detailed insights into the effect of different modalities on the disease risk.

An Explainable AI System for the Diagnosis of High Dimensional Biomedical Data

Explainable AI for computational pathology identifies model limitations and tissue biomarkers

Achievements and Challenges in Explaining Deep Learning based Computer-Aided Diagnosis Systems

ExplAIn: Explanatory Artificial Intelligence for Diabetic Retinopathy Diagnosis

An Explainable AI Paradigm for Alzheimer's Diagnosis Using Deep Transfer Learning

What do we need to build explainable AI systems for the medical domain?

Dermatologist-like explainable AI enhances trust and confidence in diagnosing melanoma

Pathologist-like explainable AI for interpretable Gleason grading in prostate cancer

Explainable Artificial Intelligence in Retinal Imaging for the detection of Systemic Diseases

Adaptive Aquila Optimizer with Explainable Artificial Intelligence-Enabled Cancer Diagnosis on Medical Imaging

Pixel-Level Explanation of Multiple Instance Learning Models in Biomedical Single Cell Images

Aligning Human Knowledge with Visual Concepts Towards Explainable Medical Image Classification

Explainable Artificial Intelligence in Alzheimer’s Disease Classification: A Systematic Review

Explainability and causability in digital pathology

Explainable AI for Medical Data: Current Methods, Limitations, and Future Directions

Towards explainable oral cancer recognition: Screening on imperfect images via Informed Deep Learning and Case-Based Reasoning

An Explainable AI Framework for Artificial Intelligence of Medical Things

Advancing Dermatological Diagnostics: Interpretable AI for Enhanced Skin Lesion Classification

A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer’s disease

ExAID: A Multimodal Explanation Framework for Computer-Aided Diagnosis of Skin Lesions